176 related articles for article (PubMed ID: 34076845)
1. Peripheral Versus Intraparenchymal Papillary Thyroid Microcarcinoma: Different Morphologies and PD-L1 Expression.
Kovacevic B; Vucevic D; Cerovic S; Eloy C
Head Neck Pathol; 2022 Mar; 16(1):200-212. PubMed ID: 34076845
[TBL] [Abstract][Full Text] [Related]
2. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
[TBL] [Abstract][Full Text] [Related]
3. Which papillary thyroid microcarcinoma should be treated as "true cancer" and which as "precancer"?
Kaliszewski K; Diakowska D; Wojtczak B; Forkasiewicz Z; Pupka D; Nowak Ł; Rudnicki J
World J Surg Oncol; 2019 May; 17(1):91. PubMed ID: 31146753
[TBL] [Abstract][Full Text] [Related]
4. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
5. Papillary thyroid microcarcinomas that metastasize to lymph nodes.
Dirikoc A; Tam AA; Ince N; Ozdemir D; Topaloglu O; Alkan A; Yazgan AK; Ersoy R; Cakir B
Am J Otolaryngol; 2021; 42(5):103023. PubMed ID: 33838358
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for lymph node metastasis (LNM) in patients with papillary thyroid microcarcinoma (PTMC): role of preoperative ultrasound.
Zhao C; Jiang W; Gao Y; Niu W; Zhang X; Xin L
J Int Med Res; 2017 Jun; 45(3):1221-1230. PubMed ID: 28534700
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
Xu Y; Xu L; Wang J
J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma.
Bai Y; Niu D; Huang X; Jia L; Kang Q; Dou F; Ji X; Xue W; Liu Y; Li Z; Feng Q; Lin D; Kakudo K
Diagn Pathol; 2017 Oct; 12(1):72. PubMed ID: 28974264
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and therapeutic outcomes of patients with papillary thyroid microcarcinomas and larger tumors.
Zheng W; Wang X; Rui Z; Wang Y; Meng Z; Wang R
Nucl Med Commun; 2019 May; 40(5):477-483. PubMed ID: 30973839
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis of the papillary thyroid microcarcinoma.
Jin S; Bao W; Yang YT; Fu Q; Bai Y; Liu Y
Ann Endocrinol (Paris); 2019 Nov; 80(5-6):293-300. PubMed ID: 31606199
[TBL] [Abstract][Full Text] [Related]
12. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
Lin KL; Wang OC; Zhang XH; Dai XX; Hu XQ; Qu JM
Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Findings Associated With Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study in China.
Shi Y; Yang Z; Heng Y; Ju H; Pan Y; Zhang Y
Cancer Control; 2022; 29():10732748221084926. PubMed ID: 35285273
[TBL] [Abstract][Full Text] [Related]
14. Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.
Shi RL; Qu N; Luo TX; Xiang J; Liao T; Sun GH; Wang Y; Wang YL; Huang CP; Ji QH
Thyroid; 2017 Apr; 27(4):537-545. PubMed ID: 27825291
[TBL] [Abstract][Full Text] [Related]
15. Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features.
Kim KE; Kim EK; Yoon JH; Han KH; Moon HJ; Kwak JY
World J Surg; 2013 Feb; 37(2):385-91. PubMed ID: 23073506
[TBL] [Abstract][Full Text] [Related]
16. Peripheral location and infiltrative margin predict invasive features of papillary thyroid microcarcinoma.
Lee WK; Lee J; Kim H; Lee SG; Choi SH; Jeong S; Kwon HJ; Jung SG; Jo YS
Eur J Endocrinol; 2019 Aug; 181(2):139-149. PubMed ID: 31146263
[TBL] [Abstract][Full Text] [Related]
17. Preoperative predictors of lateral neck lymph node metastasis in papillary thyroid microcarcinoma.
Liu Z; Lei J; Liu Y; Fan Y; Wang X; Lu X
Medicine (Baltimore); 2017 Mar; 96(10):e6240. PubMed ID: 28272218
[TBL] [Abstract][Full Text] [Related]
18. Nomograms Based on Serum
Zhang Z; Cao Z; Liu R; Li Z; Wu J; Liu X; Wu M; Xu X; Liu Z
Curr Oncol; 2022 Aug; 29(9):6018-6034. PubMed ID: 36135043
[TBL] [Abstract][Full Text] [Related]
19. Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis.
Jeon MJ; Chung MS; Kwon H; Kim M; Park S; Baek JH; Song DE; Sung TY; Hong SJ; Kim TY; Kim WB; Shong YK; Lee JH; Kim WG
Clin Endocrinol (Oxf); 2017 Jun; 86(6):845-851. PubMed ID: 28273370
[TBL] [Abstract][Full Text] [Related]
20. Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.
Karatzas T; Vasileiadis I; Kapetanakis S; Karakostas E; Chrousos G; Kouraklis G
Am J Surg; 2013 Oct; 206(4):586-93. PubMed ID: 23790258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
